Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics and long-term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort.
Namikawa K, Kamada T, Fujisaki J, Sato Y, Murao T, Chiba T, Kaizaki Y, Ishido K, Ihara Y, Kurahara K, Suga T, Suzuki H, Ito M, Hirakawa K, Maruyama Y, Gotoda T, Hosokawa O, Koike T, Mabe K, Yao T, Inui K, Iishi H, Ogata H, Furuta T, Haruma K; Collaborators. Namikawa K, et al. Dig Endosc. 2023 Sep;35(6):757-766. doi: 10.1111/den.14529. Epub 2023 Mar 28. Dig Endosc. 2023. PMID: 36721901
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y. Yagi S, et al. Among authors: namikawa k. Gastric Cancer. 2019 May;22(3):518-525. doi: 10.1007/s10120-018-0887-x. Epub 2018 Oct 17. Gastric Cancer. 2019. PMID: 30328533 Free PMC article.
Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y. Yagi S, et al. Among authors: namikawa k. Gastric Cancer. 2019 May;22(3):526. doi: 10.1007/s10120-018-0900-4. Gastric Cancer. 2019. PMID: 30467737 Free PMC article.
[Endoscopic Diagnosis Using Artificial Intelligence].
Hirasawa T, Ikenoyama Y, Horie Y, Ishioka M, Tamashiro A, Shiroma S, Namikawa K, Nakano K, Tokai Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J. Hirasawa T, et al. Among authors: namikawa k. Gan To Kagaku Ryoho. 2019 Mar;46(3):412-417. Gan To Kagaku Ryoho. 2019. PMID: 30914574 Japanese.
Detecting early gastric cancer: Comparison between the diagnostic ability of convolutional neural networks and endoscopists.
Ikenoyama Y, Hirasawa T, Ishioka M, Namikawa K, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Tsuchida T, Takeuchi Y, Shichijo S, Katayama N, Fujisaki J, Tada T. Ikenoyama Y, et al. Among authors: namikawa k. Dig Endosc. 2021 Jan;33(1):141-150. doi: 10.1111/den.13688. Epub 2020 Jun 2. Dig Endosc. 2021. PMID: 32282110 Free PMC article.
Performance of a computer-aided diagnosis system in diagnosing early gastric cancer using magnifying endoscopy videos with narrow-band imaging (with videos).
Horiuchi Y, Hirasawa T, Ishizuka N, Tokai Y, Namikawa K, Yoshimizu S, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J, Tada T. Horiuchi Y, et al. Among authors: namikawa k. Gastrointest Endosc. 2020 Oct;92(4):856-865.e1. doi: 10.1016/j.gie.2020.04.079. Epub 2020 May 15. Gastrointest Endosc. 2020. PMID: 32422155
Utilizing artificial intelligence in endoscopy: a clinician's guide.
Namikawa K, Hirasawa T, Yoshio T, Fujisaki J, Ozawa T, Ishihara S, Aoki T, Yamada A, Koike K, Suzuki H, Tada T. Namikawa K, et al. Expert Rev Gastroenterol Hepatol. 2020 Aug;14(8):689-706. doi: 10.1080/17474124.2020.1779058. Epub 2020 Jun 17. Expert Rev Gastroenterol Hepatol. 2020. PMID: 32500760 Review.
284 results